The proposed settlement would end an ongoing lawsuit against Viatris Inc. (formerly Mylan), the makers of EpiPen, that began in 2016 after public outrage over the company's decision to raise the ...

Chief executive for the now-infamous pharmaceutical company that hiked the price of the EpiPen—that ubiquitous device so many children (and plenty of adults) depend on in the event of a life ...

Here Krugman explains the real issues behind the EpiPen price hike. Follow BI Video: On Twitter More from Science Paul Krugman stopped by Business Insider to talk to senior editor Josh Barro.

Sanofi claims its Auvi-Q, a more portable epinephrine autoinjector with a retractable needle and audio instructions, couldn't compete on the unlevel playing field Mylan created for its EpiPen. (CN) — ...